IN VITRO DIAGNOSTICS Alliances Oxford Immunotec Global PLC Qiagen NV Oxford Immunotec Global PLC and Qiagen NV have settled patent infringement litigation surrounding Qiagen's QuantiFERON-TB
Completing an initial public offering ought to be a big step in company development. It is a departure from a cosseted, insulated environment of unique technical approaches and regulatory progress and
Company Changes ASHWORTH , Scott To: Cutera Inc. , EVP, Global Sales (December) From: Avinger Inc., SVP, Global Sales Phone: 415-657-5500 BROOKS , Gregory F. To: NeuroSigma Inc. , SVP, Chi
Company Changes ASHWORTH , Scott To: Cutera Inc. , EVP, Global Sales (December) From: Avinger Inc., SVP, Global Sales Phone: 415-657-5500 BAMZAI , Rakesh To: Mylan NV , Pres., India Commer